Evaluation of miR-141-3p over-expression in ovarian cancer
PDF

Keywords

Gene chips
Kyoto Encyclopedia of Genes and Genomes (KEGG)
Malignant tumors
microRNA
miR-141-3p
Molecular mechanism
Ovarian cancer
RT-qPCR
Tumor cells

How to Cite

1.
Shi L, Sun H-J, Zeng J-J, Liang Z-Q, Lin Y-H, Huang S-N, Zeng J-H, Yang L, Chen H, Luo J, Wei K-L. Evaluation of miR-141-3p over-expression in ovarian cancer. Electron. J. Biotechnol. [Internet]. 2022 Aug. 31 [cited 2024 Sep. 20];58. Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/2022.04.006

Abstract

Background: The expression of miR-141-3p in many malignant tumors has been verified. Nevertheless, the relationship between ovarian cancer and miR-141-3p remains undetermined. Therefore, further exploration is required.

Results: According to data from 100 samples, the final results of RT-qPCR showed that miR-141-3p was highly expressed in ovarian cancer. Furthermore, miR-141-3p was able to distinguish ovarian cancer cells from ovary tissues. The most significant Kyoto Encyclopedia of Genes and Genomes pathway, was regulation of lipolysis in adipocytes in ovarian cancer. The expression of PIK3R1 was negatively correlated with miR-141- 3p. PIK3R1 has a combing site with miR-141-3p.

Conclusions: This study examined the expression levels and mechanism of miR-141-3p in ovarian cancer for the first time. The results suggested that miR-141-3p may promote the occurrence of ovarian cancer by down-regulating PIK3R1.

PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.